Immunic (IMUX) Cash from Investing Activities (2013 - 2026)
Immunic (IMUX) reported Cash from Investing Activities of -$2000.0 for Q1 2026, up 95.74% on a YoY basis from -$1021.7 in Q1 2025, and up 81.82% sequentially from -$11000.0 in Q4 2025.
Immunic (IMUX) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Cash from Investing Activities data on file, last reported at -$2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 95.74% year-over-year to -$2000.0; the trailing twelve-month figure through Mar 2026 stood at -$116000.0 (up 58.57% YoY), and the FY2025 full-year result was -$161000.0, up 39.02% from the prior year.
- Cash from Investing Activities grew to -$2000.0 in Q1 2026, from -$11000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $5.3 million in Q1 2023 to a low of -$9.6 million in Q4 2022.
- A 5-year average of -$41529.4 and a median of -$36000.0 in 2025 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities sank 50573.68% in 2022 and jumped 44558.33% in 2023, its largest moves.
- Tracing IMUX's Cash from Investing Activities over 5 years: stood at -$9.6 million in 2022, then soared by 98.29% to -$165000.0 in 2023, then surged by 98.18% to -$3000.0 in 2024, then sank by 266.67% to -$11000.0 in 2025, then jumped by 81.82% to -$2000.0 in 2026.
- Business Quant data shows IMUX's Cash from Investing Activities at -$2000.0 in Q1 2026, -$11000.0 in Q4 2025, and -$67000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | Immunic | 420.10 Mn | 420.10 Mn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | -67,000.00 |
| Sep 30, 2025 | -67,000.00 |
| Jun 30, 2025 | -36,000.00 |
| Jun 30, 2025 | -36,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -50,000.00 |
| Sep 30, 2024 | -50,000.00 |
| Jun 30, 2024 | -180,000.00 |
| Jun 30, 2024 | -180,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Dec 31, 2023 | -165,000.00 |
| Dec 31, 2023 | -165,000.00 |